|
Mechanism5-HT1A receptor agonists [+2] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date10 Jul 2015 |
|
Mechanismneuraminidase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Switzerland |
First Approval Date21 Sep 1999 |
100 Clinical Results associated with Gansu Pu An Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Gansu Pu An Pharmaceutical Co., Ltd.
100 Deals associated with Gansu Pu An Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Gansu Pu An Pharmaceutical Co., Ltd.